Hilltop Holdings’s Insmed INSM Stock Holding History

Hilltop Holdings’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,215	Closed	-$385K	–	785
2025 Q4	$385K	Sell	2,215 -1,142	-34%	-$208K	0.02%	629
2025 Q3	$483K	Buy	3,357 +489	+17%	+$59.9K	0.03%	585
2025 Q2	$289K	Buy	+2,868	New	+$219K	0.02%	701

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Hilltop Holdings's INSM Position: Q1 2026 in Review

Hilltop Holdings sold out of Insmed (INSM) in Q1 2026, closing a stake of 2,215 shares — an estimated $385K sold.

Hilltop Holdings first reported a position in INSM in Q2 2025 and held it in 3 quarters. The position peaked at $483K in Q3 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

Hilltop Holdings reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
Hilltop Holdings sold 2,215 Insmed shares in Q1 2026, an estimated $385K.
Hilltop Holdings first reported a position in Insmed in Q2 2025 and held it in 3 quarters.
Hilltop Holdings's Insmed position peaked at $483K in Q3 2025.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Hilltop Holdings's 13F filing for Q1 2026, filed 14 May 2026.